Skip to main content

Want a detailed portfolio tracker?

MapLight Therapeutics (MPLT) P/E (2025 - 2026)

MapLight Therapeutics (MPLT) P/E from Dec 31, 2025 to Jun 3, 2026. The TTM MapLight Therapeutics (MPLT) P/E is -9.00. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of MapLight Therapeutics (MPLT)

YearP/EChange
2026-9.00-7.42%
2025-9.72N/A

Comparison MapLight Therapeutics (MPLT) P/E with competitors

MapLight Therapeutics (MPLT) P/E is -9.00.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-101.14%
ENLVEnlivex Therapeutics Ltd0.15-101.67%
FGENFibroGen Inc0.24-102.67%
TRAWTraws Pharma Inc0.47-105.25%
FBIOFortress Biotech Inc0.71-107.84%
CHRSCoherus Biosciences Inc0.98-110.87%
ORMPOramed Pharmaceuticals Inc1.47-116.37%
AGENAgenus Inc2.05-122.76%
VIVSVivoSim Labs Inc2.54-128.18%
INVAInnoviva Inc3.19-135.43%
CRMDCorMedix Inc3.65-140.51%
ABEOAbeona Therapeutics Inc4.20-146.72%
VXRTVaxart Inc4.26-147.35%
CVACCureVac N.V.4.45-149.40%
SRPTSarepta Therapeutics Inc4.62-151.38%
GLPGGalapagos NV4.86-153.99%
RIGLRigel Pharmaceuticals4.92-154.66%
ZVRAZevra Therapeutics Inc4.97-155.27%
ABUSArbutus Biopharma Corp5.69-163.26%
CGENCompugen Ltd7.38-182.04%
AUPHAurinia Pharmaceuticals Inc9.25-202.79%
ACADAcadia Pharmaceuticals Inc9.59-206.53%
OMEROmeros Corporation9.88-209.82%
PLXProtalix BioTherapeutics Inc9.91-210.10%
SPROSpero Therapeutics Inc10.73-219.28%
ADMAAdma Biologics Inc11.33-225.90%
SVASinovac Biotech Ltd11.44-227.07%
TBPHTheravance Biopharma Inc11.78-230.85%
HRMYHarmony Biosciences Holdings Inc12.18-235.34%
TGTXTG Therapeutics Inc13.18-246.44%
INCYIncyte Corp13.38-248.69%
SABSSAB Biotherapeutics Inc14.06-256.20%
XOMAXOMA Corp14.95-266.06%
REGNRegeneron Pharmaceuticals Inc14.98-266.45%
PBYIPuma Biotechnology Inc15.05-267.23%
EXELExelixis Inc15.79-275.50%
NAGENiagen Bioscience Inc16.35-281.72%
CPRXCatalyst Pharmaceuticals Inc17.34-292.72%
MDXGMimedx Group Inc17.38-293.06%
ARGXArgen X SE23.07-356.35%
HALOHalozyme Therapeutics Inc23.20-357.79%
XOMAOXOMA Corp25.34-381.61%
VRTXVertex Pharmaceuticals Inc25.66-385.07%
XOMAPXOMA Corp25.67-385.23%
CTMXCytomX Therapeutics Inc25.70-385.54%
ASNDAscendis Pharma A/S26.35-392.83%
RPRXRoyalty Pharma plc - Class A27.50-405.51%
SLNOSoleno Therapeutics Inc29.02-422.40%
LGNDLigand Pharmaceuticals Inc - Class B30.19-435.41%
BMRNBiomarin Pharmaceutical Inc37.51-516.75%
APLSApellis Pharmaceuticals Inc39.02-533.57%
KRYSKrystal Biotech Inc39.70-541.09%
GMABGenmab40.20-546.71%
ONCBeiGene Ltd67.03-844.76%
TECHBio-Techne Corp68.59-862.18%
VCELVericel Corp80.63-995.89%
PHARPharming Group N.V.87.74-1074.91%
ALNYAlnylam Pharmaceuticals Inc124.93-1488.17%
TLXTelix Pharmaceuticals Ltd139.89-1654.36%
CORTCorcept Therapeutics Inc158.39-1859.91%